Neuromeningeal cryptococcosis and HIV infection: A series of 6 cases in Tunisia;Cryptococcose neuro-meningee et infection par le virus de l'immunodeficience humaine (VIH) experience tunisienne a propos de 6 cas

Journal de Mycologie Medicale

Volumn 7, Issue 2, 1997, Pages 97-99

  Kilani, B ^a   Goubontini, A ^a   Gastli, M ^a   Tiouiri, H ^a   Belhadj, S ^a   Ben Chaabane T ^a   Zouiten, F ^a   Chaker, E ^a   Zribi, A ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

AIDS; Amphotericin B; Cryptococcosis; Fluconazole; Tunisia

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADULT; ARTICLE; CEREBROSPINAL FLUID CULTURE; CLINICAL ARTICLE; FEMALE; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; MALE; OPPORTUNISTIC INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030762486     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-9.
2. Coker RJ, Viviani M, Gazzard BG, Dupont B, Pohle HD, Murphy SM et al. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 1993;7:829-35.
3. De Lalla F, Pellizer G, Vaglia A, Manfrin V, Franzetti M, Fabris P et al. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. Clin Infect Dis 1995;20:263-6.
4. Denning DW, Tucker RM, Hanson LM, Hamilton JR, Stevens DA. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989;149:2301-8.
5. Dromer F, Ronin O, Dupont B et les membres du Groupe d'Étude des Mycoses Profondes (GEMO). Données épidémiologiques du centre de référence sur la cryptococcose en France. Med Mal Infect 1994;24(spécial):576-9.
6. Dromer F, Mathoulin S, Dupont B, Laporte A, and the French cryptococcosis Study Group. Epidemiology of cryptococcosis in France: a 9-year-survey (1985-1993). Clin Infect Dis 1996;25:82-90.
7. Gordon MA, Casaderall A. Serum therapy for cryptococcal meningitis. Clin Infect Dis 1995;21:1477-9.
8. Meyohas MC, Meynard JL, Poirot JL, Frottier J. Apport des azolés dans le traitement des cryptococcoses. Med Mal Infect 1995;25:58-62.
9. Pinner RW, Hajjeh RA, Powderly WG. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21(suppl 1):S103-7.
10. Powderly WG. Management of cryptococcal meningitis. Have we answered all the questions? Clin Infect Dis 1996;22:329-30.
11. Rosenbaum R, Gonçalves AJR. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994;18:369-80.
12. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK et al. and the NIAID mycoses study group and the AIDS clinical trials group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
13. Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996;22:315-21.